Psyence Group Company Description

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions.

It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand.

The company was founded in 2019 and is based in Toronto, Canada.

Psyence Group Inc.

Country	Canada
Founded	2019
Industry	Drug Manufacturers - General
Sector	Healthcare

Contact Details

Address: 121 Richmond Street West Toronto, Ontario M5H 2K1 Canada
Phone	416-477-1708
Website	psyence.com

Stock Details

Ticker Symbol	PSYG
Exchange	Canadian Securities Exchange
Fiscal Year	April - March
Reporting Currency	CAD
ISIN Number	CA74449Q1063
SIC Code	2836

Key Executives

Name	Position
Jody Aufrichtig	Co-Founder and Executive Chairman
Adri Botha	Interim Chief Financial Officer
Taryn Vos	General Counsel
Tony Budden	Chief Strategy Officer
Mary-Elizabeth Gifford	Executive Vice President for Public Policy and Global Impact